Private Equity

Updated:

Tar Heel Capital

Tar Heel Capital is a private equity firm managing THC IV, a €120M fund closed and focused on the development of Polish medium-sized enterprises, with...

Tar Heel Capital logo

Tar Heel Capital

Tar Heel Capital is a private equity firm managing THC IV, a €120M fund closed and focused on the development of Polish medium-sized enterprises, with particular emphasis on succession planning by Polish entrepreneurs. The firm operates from offices in Warsaw and Szczecin. Its current portfolio includes a Polish producer of ecological paper packaging, a Polish producer of aluminum components, and a medical center.

General information

Firm type

Private Equity

Year founded

1998

Location

Region

Europe

Country

Poland

City

Warsaw

Corporate office

Warsaw, Poland

Sector focus

packagingaluminum manufacturinghealthcare

Frequently asked questions

What investment strategies does Tar Heel Capital pursue?

Public records describe a multi-strategy approach covering venture capital from seed through late-stage, growth equity, and buyout transactions including management buyouts, divestitures, and corporate restructurings. The firm blends early-stage venture origination with control-oriented private equity, operating across the full company lifecycle.

Where does Tar Heel Capital invest geographically?

Tar Heel Capital is headquartered in Warsaw, Poland, and targets investments across Central Europe. The broader Central European corridor, with its fragmented private markets and succession-driven deal flow, forms the firm's primary geographic focus, though specific country allocations have not been publicly disclosed.

Is Tar Heel Capital a single family office or a traditional private equity firm?

Tar Heel Capital is structured as an asset manager operating a private equity strategy, not a family office. Its multi-stage mandate — spanning venture, growth, and buyout — reflects an institutional private equity posture rather than proprietary family capital management, though its investor base has not been publicly identified.

Does Tar Heel Capital participate in venture-stage or only control buyouts?

Tar Heel Capital's disclosed strategy includes both venture and buyout stages. The firm lists early-stage seed and start-up venture alongside expansion, growth, and buyout transactions, indicating active participation across the full company lifecycle rather than a stage-constrained mandate.

Has Tar Heel Capital raised institutional funds?

No publicly available records confirm a disclosed fund series or institutional fundraise. The firm may operate on a deal-by-deal syndication basis or maintain a deliberately private capital base, as no limited partner commitments or vehicle sizes have been reported in standard industry databases.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Warsaw Private Equity profiles